Use this dropdown to select your preferred language.
We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, the planet and our shareholders. We push the boundaries of science to deliver life-changing medicines. Our bold aspiration is to be pioneers in science, lead in our disease areas and transform patient outcomes.
We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.
Distribution of pharmaceutical products
Angelini Pharma, Akıl Sağlığı, Epilepsi alanlarında uzmanlığı ve Tüketici Sağlığı markalarıyla sağlık sektöründe lider konumda olan şirketlerden biridir. Angelini Pharma, 3.000’den fazla çalışanı ile 20 ülkede doğrudan faaliyet göstermektedir. Ayrıca önde gelen uluslararası ilaç şirketleriyle stratejik işbirlikleri kurarak, ürünlerinin 70’den fazla ülkede satış ve pazarlama faaliyetlerinin yürütülmesini sağlamaktadır.
As a medium-sized consulting and planning company, we support our clients in complex industrial projects. From production, logistics, SAP and cloud solutions to architecture, operational excellence, building services and project management – with our “Lead Consulting // plus” approach, we shape the future holistically.
Our culture is characterized by team spirit, trust and the ambition to become better together.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolic and Respiratory & Immunology. Our company is led with a people-first mindset and a leadership strategy that respects the importance of entrepreneurial and team-driven innovation.
作为首批进入中国的跨国制药企业之一，施维雅深耕中国市场的43年里，一直专注于心脏健康、高血压、糖尿病和静脉健康领域，为中国患者提供高质量药物和综合健康解决方案。随着第一款胰腺癌药物在2022年4月获批，施维雅中国也紧随集团步伐正式启动肿瘤领域的工作。秉持“成为肿瘤领域的卓越贡献者”这一愿景, 施维雅中国在难治性肿瘤方面布局了丰富的产品管线，包括结直肠癌、中枢神经系统肿瘤等，为患者带来更多样的治疗选择，改善生命质量。
Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. Being a truly global company, we work in over 60 countries and serve patients in more than 140 countries.
Ipsen avec 5 700 collaborateurs dans le monde est un groupe biopharmaceutique de taille moyenne focalisé sur des médicaments innovants en Oncologie, Maladie Rare et Neurosciences. Ipsen qui commercialise plus de 20 médicaments dans plus de 115 pays est également présent en Santé Familiale. La R&D d’Ipsen est située au cœur de clusters mondiaux tels que Paris-Saclay, France ; Oxford, UK ; Cambridge, US et enfin Shanghai, Chine.
ABB is a technology leader in electrification and automation, enabling a more sustainable and resource-efficient future. The company’s solutions connect engineering know-how and software to optimize how things are manufactured, moved, powered and operated. Building on more than 140 years of excellence, ABB’s ~105,000 employees are committed to driving innovations that accelerate industrial transformation
En tant que leader mondial de la santé animale, Zoetis est animée par un objectif unique : nourrir notre monde et l’Humanité en faisant progresser les soins aux animaux. Depuis plus de 70 ans, Zoetis innove pour prédire, prévenir, détecter et traiter les maladies animales tout en soutenant les personnes qui élèvent et soignent des animaux dans le monde entier, qu’il s’agisse de vétérinaires, de propriétaires d’animaux de compagnie ou d’éleveurs.
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.